COVID-19 Pandemic
In March 2020, the World Health Organization declared the novel coronavirus 2019 (“COVID-19”) a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, potentially leading to an economic downturn. While it is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak, including as a result of the emergence of variant strains of the virus and ongoing vaccination efforts, and its ultimate effects on the Company’s business, results of operations or ability to raise funds at this time, as of the date of this Quarterly Report on Form 10-Q, the COVID-19 pandemic has not had any material adverse effects on the Company.
Results of Operations
Summary of Quarterly Results
| | | | | | | | | | | | |
Description | | March 31, 2022 | | December 31, 2021 | | September 30, 2021 | | June 30, 2021 |
Net income (loss) | | $ | (713,973) | | $ | (1,015,489) | | $ | (1,648,913) | | $ | (2,178,014) |
Basic and diluted net gain (loss) per common share | | $ | (0.00) | | $ | (0.01) | | $ | (0.01) | | $ | (0.01) |
| | | | | | | | | | | | |
| | March 31, 2021 | | December 31, 2020 | | September 30, 2020 | | June 30, 2020 |
Net income (loss) | | $ | (1,137,872) | | $ | (1,995,576) | | $ | (1,101,763) | | $ | (1,486,464) |
Basic and diluted net gain (loss) per common share | | $ | (0.01) | | $ | (0.01) | | $ | (0.01) | | $ | (0.01) |
Three Months Ended March 31, 2022 compared to Three Months Ended March 31, 2021
The Company had a net loss of $713,973 for the three months ended March 31, 2022, compared to a net loss of $1,137,872 for the three months ended March 31, 2021.
Mineral property expenditures were $203,093 for the three months ended March 31, 2022, compared to $539,754 for the three months ended March 31, 2021. The decrease of $336,661 is primarily due to the completion of the PFS for the Livengood Gold Project, which amounted to a decrease of $314,519, and timing variance on environmental and legal costs, which amounted to a decrease of $22,142, which expenditures were made during the three months ended March 31, 2021 and not repeated during the three months ended March 31, 2022.
Excluding share-based costs of $25,246 and $15,623 for the three months ended March 31, 2022 and March 31, 2021, respectively, wages and benefits were $104,303, for the three months ended March 31, 2022 compared to $147,627, for the three months ended March 31, 2021. The decrease of $43,324 is primarily due to a variation in timing of employee benefits.
Regulatory costs were $73,696 for the three months ended March 31, 2022 compared to $100,023 for the three months ended March 31, 2021. The decrease of $26,327 is primarily due to reduced SEDAR annual fees of ($18,820) and reduced Toronto Stock Exchange (“TSX”) listing fees of $12,658, partially offset by increased filing expenses related to the TRS for the Livengood Gold Project filed as Exhibit 96.1 to our Annual Report on Form 10-K for the year ended December 31, 2021 of $5,151.
Excluding share-based costs of $1,803 and $1,116 for the three months ended March 31, 2022 and March 31, 2021, respectively, investor relations costs were $13,450 for the three months ended March 31, 2022 compared to $11,077 for the three months ended March 31, 2021. The increase of $2,373 is primarily due to increased investor relations conferences and services.
Professional fees were $66,233 for the three months ended March 31, 2022 compared to $46,641 for the three months ended March 31, 2021. The increase of $19,592 is primarily due to the legal review of the TRS for the Livengood Gold Project of $11,977, a timing variance for the SOX review services of $6,035, and additional iXBRL services of $1,580.